未登录The Impact of Model Assumptions on Personalized Lung Cancer Screening Recommendations
ten Haaf, Kevin; de Nijs, Koen; Simoni, Giulia; Alban, Andres; Cao, Pianpian; Sun, Zhuolu; Yong, Jean; Jeon, Jihyoun; Toumazis, Iakovos; Han, Summer S.; Gazelle, G. Scott; Kong, Chung Ying; Plevritis, Sylvia K.; Meza, Rafael; de Koning, Harry J. .png)
分享.png)
收藏QSPcc reduces bottlenecks in computational model simulationsTomasoni, Danilo; Paris, Alessio; Giampiccolo, Stefano; Reali, Federico; Simoni, Giulia; Marchetti, Luca; Kaddi, Chanchala; Neves-Zaph, Susana; Priami, Corrado; Azer, Karim; Lombardo, Rosario 分享 收藏 分享 收藏 A Quantitative Systems Pharmacology Model of Gaucher Disease Type 1 Provides Mechanistic Insight Into the Response to Substrate Reduction Therapy With EliglustatAbrams, Ruth; Kaddi, Chanchala D.; Tao, Mengdi; Leiser, Randolph J.; Simoni, Giulia; Reali, Federico; Tolsma, John; Jasper, Paul; van Rijn, Zachary; Li, Jing; Niesner, Bradley; Barrett, Jeffrey S.; Marchetti, Luca; Peterschmitt, M. Judith; Azer, Karim; Neves-Zaph, Susana 分享 收藏 分享 收藏 Integrated quantitative systems pharmacology (QSP) model of lysosomal diseases provides an innovative computational platform to support research and therapeutic development for the sphingolipidosesKaddi, Chanchala; Reali, Federico; Marchetti, Luca; Niesner, Bradley; Parolo, Silvia; Simoni, Giulia; Zaph, Susana; Tao, Mengdi; Abrams, Ruth; van Rijn, Zachary; Leonard, John; Peterschmitt, M. Judith; Puga, Ana Cristina; Mange, Kevin; Barrett, Jeffrey S.; Priami, Corrado; Schuchman, Edward H.; Azer, Karim 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
